WHO naming stem · suffix · 83 listed names
-imod
This page was written with AI.
immunomodulators, both stimulant/suppressive and stimulant
Where it sits in a name
WHO writes the stem as -imod. So the letters imod sit at the end of the name (…imod).
All 83 names WHO lists under -imod
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 7 of 83 names appear in these lists: 7 in the US list (FDA Drugs@FDA) and 7 in the EU central list (EMA); 8 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- acumapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- adezmapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- agatolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alintegimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amiselimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- apilimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atiprimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- balamapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bentamapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bevifimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- blisibimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cavrotolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cenerimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ceralifimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cobitolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cridanimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cupabimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- defoslimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dilmapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- doramapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- efgartigimod alfaUS brands: VYVGARTEU (central) brands: Vyvgart
- efizonerimod alfaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- efprezimod alfaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- eftilagimod alfaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- efzofitimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emprumapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- entolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- epetirimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- esonarimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etrasimodUS brands: VELSIPITYEU (central) brands: Velsipity
- fingolimodUS brands: GILENYA
- forigerimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glaspimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- golotimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- guretolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- icanbelimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- iguratimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imiquimod
- indoximodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ivarimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lapretolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- laquinimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lefitolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- litenimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- losmapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mocravimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mosedipimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- motolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- navoximodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- neflamapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- obefazimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- orilotimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ozanimodUS brands: ZEPOSIAEU (central) brands: Zeposia
- pamapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- paquinimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pegtarazimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pidotimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pixatimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- polvitolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ponesimodUS brands: PONVORYEU (central) brands: Ponvory
- rabeximodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- reltecimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- resiquimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- resiquimod pegolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rintatolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ruzotolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- selgantolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- semapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- siponimodUS brands: MAYZENTEU (central) brands: Mayzent
- sotirimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- susalimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- talmapimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tamuzimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tasquinimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telratolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tilsotolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tiprotimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- udifitimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vesatolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vibozilimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vidutolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vonifimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- xempritolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
apilimod
Listed INNCarries the WHO stem -imod
- -imodend of the nameWHO lists it hereWHO definition: immunomodulators, both stimulant/suppressive and stimulant
“apilimod” is an INN that WHO lists under -imod in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -imod (Part II B) and the 83 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.